XBI
State Street SPDR S&P Biotech ETFstockNYSEETF
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 155.06 | 2026-11-10 | -7.11% | 1.215 |
| 1M | 144.32 | 2026-10-16 | -0.20% | 1.530 |
| 3M | 159.53 | 2026-08-17 | -9.71% | 1.447 |
| 6M | 127.67 | 2026-05-18 | +12.82% | 1.119 |
| 1Y | 114.83 | 2025-11-17 | +25.43% | 1.183 |
| 2Y | 91.96 | 2024-11-18 | +56.63% | — |
| 5Y | 122.93 | 2021-11-17 | +17.17% | 1.143 |
State Street SPDR S&P Biotech ETF (NYSE:XBI) stock price today is $144.04, and today's volume is 3,611,419. XBI is down 1.265% today. The 30 day average volume is 9.70M. XBI market cap is $9.76B with 67.78M shares outstanding.